After months of consideration, CMS has officially signed off on major changes to its TAVR policies. The treatment of asymptomatic patients is now covered by Medicare, for example, and fewer reporting requirements are in place when symptomatic patients undergo treatment.

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

Cardiologists have always wanted a better way to identify heart patients in need of care early in their course of disease. Artificial intelligence may be the tool physicians have been waiting for. 

When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.

TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.

CMS just finalized significant changes to its TAVR coverage policies. Three leading cardiovascular health societies shared a joint statement summarizing their initial feedback. 

The Emboliner Embolic Protection System held its own in a recent head-to-head comparison with Boston Scientific’s Sentinel Cerebral Protection System. With FDA approval now secured, Emboline hopes to launch the device in the months ahead. 

Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 

A majority of TAVR patients also present with a history of heart failure. New research suggests many of them are not being prescribed the medications they need.